|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-2-6
|
|
pubmed:abstractText |
Isobologram analysis has been widely used for evaluating the combined effect of two antitumor drugs in vitro as a pre-clinical screening test. In this study, we tried to extend two-dimensional isobologram analysis to three dimensions for evaluating the effects of a three-drug combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
199-204
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8996520-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8996520-Camptothecin,
pubmed-meshheading:8996520-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8996520-Cisplatin,
pubmed-meshheading:8996520-Drug Screening Assays, Antitumor,
pubmed-meshheading:8996520-Humans,
pubmed-meshheading:8996520-Lung Neoplasms,
pubmed-meshheading:8996520-Tumor Cells, Cultured,
pubmed-meshheading:8996520-Vinblastine
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro.
|
|
pubmed:affiliation |
First Department of Internal Medicine, Nagoya University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article
|
